Back to search results

Stephanie Christenson, MD, MS

Chronic Obstructive Pulmonary Disease

Lung Health Center at Parnassus
400 Parnassus Ave., Sixth Floor, Room A6114,
San Francisco, CA 94143

Virtual visits available

Lung Health Center at Parnassus
400 Parnassus Ave., Sixth Floor, Room A6114,
San Francisco, CA 94143

About me

Insurance plan info

Dr. Stephanie Christenson cares for patients in the intensive care unit as well as patients with lung disease in the clinic.

In her research, Christenson uses gene-analyzing technologies to identify patients with asthma or chronic obstructive pulmonary disease who may respond better to specific therapies based on their underlying biology.

Christenson earned her medical degree from the Medical College of Wisconsin. She completed a residency in internal medicine at Boston University School of Medicine. At UCSF, she completed a fellowship in pulmonary and critical care medicine and a master of advanced study degree in clinical research.

Christenson is a member of the American Thoracic Society.

Board Certifications

American Board of Internal Medicine, Critical Care Medicine, 2014
American Board of Internal Medicine, Pulmonary Disease, 2012
Fellowships

UCSF, Pulmonary, Critical Care, and Sleep Medicine, 2014
Residencies

Boston Medical Center, Internal Medicine, 2009
Internship

Boston Medical Center, Internal Medicine, 2007
Degree

Medical College of Wisconsin, 2006
Languages

English

Where I see patients (1)

Selected research

See all research

Mepolizumab to Prevent Exacerbations of COPD with an Eosinophilic Phenotype.
The New England journal of medicine
May 2025
Learn more
Dupilumab reduces acute exacerbations and improves lung function in patients with COPD with type 2 inflammation irrespective of body mass index, airflow obstruction, dyspnea, and exercise capacity index scores.
Respiratory medicine
February 2025
Learn more
Clinical and Biological Features of a Thickened Basement Membrane Zone in Asthma.
American journal of respiratory and critical care medicine
February 2025
Learn more

Clinical trials

See all clinical trials

Clinical Trial of Omalizumab for Allergen Sensitized and Exposed Individuals With COPD

To determine the efficacy of omalizumab injection in reducing the annualized rate of moderate or severe exacerbations (primary outcome) over the course of 12 months among individuals with COPD having sensitization and exposure to ...

Recruiting

American Lung Association (ALA) Lung Health Cohort

Pre-bronchodilator measurements of FEV1 to determine bronchoconstriction. FEV1 is measured in liters of air. Severity of bronchoconstriction is based on predicted values published by National Health and Nutrition Examination Surve...